Abstract: A surface warming diathermy apparatus and method includes an applicator with a first chamber and a second chamber where the first chamber contains a dielectric solution. A primary coil is wrapped around the applicator beginning with the first chamber. A secondary coil is wrapped around the applicator also beginning with the first chamber and a RF energy source connected with the primary coil. The apparatus is tuned to a near resonant state by means of a variable high-voltage capacitor connected to each end of the secondary coil.

Abstract: An RF diathermy coil assembly includes a patient-conforming garment defining a passage for receiving a body part therein and a primary coil including a number of windings disposed around the passage. The primary coil is connectable to a power source lead and is incorporated into the patient-conforming garment. The primary coil is responsive to RF power delivered via the power source lead for establishing an RF field. A secondary coil is provided that includes a number of windings disposed around the passage. The secondary coil is disposed proximate the primary coil and is incorporated into the patient-conforming garment. A tuner is coupled to the secondary coil for tuning the RF field to a resonant frequency of the body part disposed within the passage.

Abstract: An RF diathermy coil assembly, including a generally elastically deformable patient conforming garment and a conductive coil secured to the garment. The conductive coil having a woven wire construction such that the coil can deform as the garment elastically deforms. The RF diathermy coil assembly can be used for wound healing in conjunction with muscle stimulation.

Abstract: An RF diathermy coil assembly, including a generally elastically deformable patient conforming garment and a conductive coil secured to the garment. The conductive coil having a woven wire construction such that the coil can deform as the garment elastically deforms. The RF diathermy coil assembly can be used for wound healing in conjunction with muscle stimulation.

Abstract: An RF diathermy coil assembly, including a generally elastically deformable patient conforming garment and a conductive coil secured to the garment. The conductive coil having a woven wire construction such that the coil can deform as the garment elastically deforms. The RF diathermy coil assembly can be used for wound healing in conjunction with muscle stimulation.

Abstract: An RF diathermy coil assembly, including a generally elastically deformable patient conforming garment and a conductive coil secured to the garment. The conductive coil having a woven wire construction such that the coil can deform as the garment elastically deforms. The RF diathermy coil assembly can be used for wound healing in conjunction with muscle stimulation.

Abstract: An RF diathermy coil assembly, including a generally elastically deformable patient conforming garment and a conductive coil secured to the garment. The conductive coil having a woven wire construction such that the coil can deform as the garment elastically deforms. The RF diathermy coil assembly can be used for wound healing in conjunction with muscle stimulation.

Abstract: An RF diathermy coil assembly, including a generally elastically deformable patient conforming garment and a conductive coil secured to the garment. The conductive coil having a woven wire construction such that the coil can deform as the garment elastically deforms. The RF diathermy coil assembly can be used for wound healing in conjunction with muscle stimulation.

Abstract: The present invention broadly relates to a therapeutic agent effective in mitigating disease associated with Feline Leukemia Virus (FeLV) in a feline infected with FeLV. A feline is an animal of the family Felidae. The novel therapeutic agent is composed of feline excised lymph nodes which have been subjected to mitogenic stimulation for their expansion dispersed in a pharmaceutically-acceptable carrier. Mitogenic stimulation conditions include culturing the excised lymph nodes in the presence of Interleukin-2. Optionally, culture conditions can include the presence of allogeneic or autologous FeLV tumor. The inventive therapeutic agent is prepared by excising lymph nodes from a feline infected the FeLV, mitogenically stimulating said excised lymph nodes for their expansion, and administering to the infected feline the expanded lymph nodes. Multidose regimens can be used as is necessary or desirable in convenient fashion.

Abstract: A vaccine for the prevention of disease caused by feline infectious peritonitis virus (FIPV) which comprises FIP viral precursor immunogens derived from in vitro produced cells persistently infected with FIPV. A method of producing FIP viral precursor immunogens is disclosed which comprises culturing in vitro FIP-persistently infected cells in a serum-containing growth medium, subsequently transferring and maintaining said cultured cells in a serum-free medium under conditions for a time adequate to accumulate FIP viral precursor immunogens shed from said cells, and then separating the cells from the supernatant containing the viral precursor immunogens. Any live virus present in the mixture is inactivated and the supernatant containing the FIP viral precursor immunogens is blended with a pharmaceutically-acceptable adjuvant in order to form the FIP vaccine disclosed herein.

Abstract: A self-contained personal microwave and RF detector, which includes, inter alia, the housing and associated electronics of a standard hearing aid, is configured to produce an audible indication to a wearer thereof in response to electromagnetic fields of dangerously high levels within predetermined frequency ranges.

Abstract: One aspect of the present invention comprises a vaccine for the prevention of disease caused by feline infectious peritonitis virus (FIPV). Such vaccine comprises FIP viral precursor immunogens derived from in vitro produced cells persistently infected with FIPV. Preferred in the production of viral immunogens forming the vaccine of the present invention is the Crandall Feline Kidney (CrFK) cell line. Thus, a second aspect of the invention comprises FIP-infected Crandall Feline Kidney cell line, deposited at the American Type Culture Collection (ATCC), Rockville, MD, on Sep. 23, 1992, and granted Accession No. CRL11137.

Abstract: Disclosed is a vaccine for the prevention of disease caused by canine distemper virus (CDV). The vaccine is prepared from CDV immunogens derived from CDV persistently-infected cells cultured in vitro. CCL-64 mink lung cells are the preferred cell line. CDV persistently-infected cells are cultured in serum-containing growth medium, the cells transferred and maintained in serum-free medium under conditions and for a time adequate to accumulate in said serum-free medium said CDV immunogens, and the cells separated from said CDV immunogen-containing supernatant. The CDV vaccine is made by diluting said supernatent and blending with a pharmaceutically-acceptable adjuvant.

Abstract: The invention is a device encompassing and warming the extremity of a wor in a cold wet environment. The device can take the form of a glove, sock and/or arm and/or leg warmer. The device contains a coil surrounding the extremity. The coil forms an envelope surrounding each extremity and each digit of an extremity. A water free, RF transmitting zone encompasses the coil envelope. The coil, extremity and RF transmitting zone combine to provide a resonant frequency with the operating frequency with which the coil is driven. The combination warms the interior of the extremity. The RF energy is provided from a source carried at some other point on the subjects body. The entire combination on each extremity and the power source can be encompassed in a shield layer which absorbs or reflects RF energy into the extremity.

Abstract: Method and apparatus for use in measuring SAR (Specific Absorption Rate) of persons subject to RF (radio frequency) radiation utilizes twin well calorimetry including first and second gradient-layer type calorimetry boxes the thermally conductive walls and cover of which contain a multiplicity of thermocouples the outputs of which are differentially amplified to provide a differential output. Identical body models that are thermally responsive to RF radiation are contained in the box wells and, after a period of thermal equalization outside the influence of the RF source, one body model is removed from its well and placed in the influence of the radiation in question while the other remains outside the influence. After a predetermined time period the irradiated model is returned to its well and the differential outputs is plotted over a time period. The area under the resultant curve is representative of total absorption from which can readily be calculated SAR.

Abstract: An apparatus and method for rewarming hypothermia victims utilizes mutually nductive first and second helical coils supported in spaced relation around a subject's torso, the combination of coils and subject having a resonant frequency in the 2 MHz to 20 MHz radio frequency range. An automatic tuner couples an RF generator to energize the coils at the resonant frequency. A portable version utilizes flexible coils on an insulating and spacing jacket having a zippered opening with conductive teeth to complete coil turns.

Abstract: Disclosed is a vaccine which prevents disease caused by Feline leukemia virus (FeLV) and which comprises a protease enzyme-inhibited, cell-free, ostensibly virusfree, in vitro produced feline leukemia neoantigens including FOCMA which evokes an immune response in cats by the appearance of antibodies thereto and a FeLV virion gp70 neoantigen which evokes an immune response in cats by the appearance of antibodies thereto. A novel method for making the vaccine is disclosed also.